First AD

Second AD

Prevalence of Cardiovascular Disease

Video content above is prompted by the following:

Can you review the current prevalence and effects of cardiovascular disease in the United States?

In your opinion, what is contributing to the “rising tide” of this disease?

Please discuss the importance of dyslipidemia management in preventing and managing atherosclerotic cardiovascular disease (ASCVD).

Clinical

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Video Series

From LDL-C to Lp(a): A Multispecialty Approach to Reducing the Rising Tide of Cardiovascular Disease

Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in the United States, with a significant prevalence affecting millions. Contributing factors to the increasing incidence include lifestyle changes, obesity, diabetes, and hypertension. Dyslipidemia management is crucial in preventing and managing atherosclerotic cardiovascular disease (ASCVD) as it directly influences lipid levels, reducing the risk of plaque formation and subsequent cardiovascular events. Effective management strategies, including lifestyle modifications and pharmacotherapy, are essential in mitigating the impact of CVD and improving patient outcomes.

Panelists discuss how cardiovascular disease remains a leading health concern in the United States, examining its rising prevalence, risk factors such as dyslipidemia, and management strategies aligned with AHA guidelines to reduce patient mortality.

AHA Guidelines and Patient Mortality 

Role of LDL-C in ASCVD